title: Decision-making critical amino acids: role in designing peptide vaccines for eliciting Th1 and Th2 immune response.
abstract: CD4 T cells play a cardinal role in orchestrating immune system. Differentiation of CD4 T cells to Th1 and Th2 effector subsets depends on multiple factors such as relative intensity of interactions between T cell receptor with peptide-major histocompatibility complex, cytokine milieu, antigen dose, and costimulatory molecules. Literature supports the critical role of peptide's binding affinity to Human Leukocyte Antigens (HLAs) and in the differentiation of naïve CD4 T cells to Th1 and Th2 subsets. However, there exists no definite report addressing very precisely the correlation between physicochemical properties (hydrophobicity, hydrophilicity), pattern, position of amino acids in peptide and their role in skewing immune response towards Th1 and Th2 cells. This may play a significant role in designing peptide vaccines. Hence in the present study, we have evaluated the relationship between amino acid pattern and their influence in differentiation of Th1 and Th2 cells. We have used a data set of 320 peptides, whose role has been already established experimentally in the generation of either Th1 or Th2 immune response. Further, characterization was done based on binding affinity, promiscuity, amino acid pattern and binding conformation of peptides. We have observed that distinct amino acids in peptides elicit either Th1 or Th2 immunity. Consequently, this study signifies that alteration in the sequence and type of selected amino acids in the HLA class II binding peptides can modulate the differentiation of Th1 and Th2 cells. Therefore, this study may have an important implication in providing a platform for designing peptide-based vaccine candidates that can trigger desired Th1 or Th2 response.
authors.affiliation: Immunology Laboratory, CSIR-Institute of Microbial Technology, Chandigarh, 160036, India.
authors.forename: Khurram
authors.initials: K
authors.lastname: Mushtaq
authors.forename: Sathi Babu
authors.initials: SB
authors.lastname: Chodisetti
authors.forename: Pradeep K
authors.initials: PK
authors.lastname: Rai
authors.forename: Sudeep K
authors.initials: SK
authors.lastname: Maurya
authors.forename: Mohammed
authors.initials: M
authors.lastname: Amir
authors.forename: Javaid A
authors.initials: JA
authors.lastname: Sheikh
authors.forename: Javed N
authors.initials: JN
authors.lastname: Agrewala
mesh_terms: D000595:Amino Acid Sequence; D015195:Drug Design; D000949:Histocompatibility Antigens Class II / Q000737:chemistry / Q000276:immunology; D006801:Humans; D008958:Models, Molecular; D018417:Th1 Cells / Q000276:immunology*; D018418:Th2 Cells / Q000276:immunology*; D022223:Vaccines, Subunit / Q000737:chemistry* / Q000276:immunology*
chemical_list: D000949:Histocompatibility Antigens Class II; D022223:Vaccines, Subunit